Méndez-Vidal, María José http://orcid.org/0000-0002-7460-1859
Lázaro Quintela, Martin
Lainez-Milagro, Nuria
Perez-Valderrama, Begoña
Suárez Rodriguez, Cristina
Arranz Arija, José Ángel
Peláez Fernández, Ignacio
Gallardo Díaz, Enrique
Lambea Sorrosal, Julio
González-del-Alba, Aránzazu
Article History
Received: 30 June 2023
Accepted: 1 July 2023
First Online: 9 August 2023
Declarations
:
: MJMV reports Advisory Board—Speaker—Non-financial Support from BMS and Merck; Advisory Board—Speaker from Pfizer; Advisory Board from EISAI and MSD; Speaker from Eusa; Speaker—Non-financial Support from ROCHE; Advisory Board—Non-financial Support from ASTRA ZENECA; from Ipsen. MLQ reports Speaker from Eisai and BMS; Advisory Board—Speaker from Roche, Astellas, AstraZeneca, Sanofi and Merck; Advisory Board—Speaker—Grant from MSD and Ipsen; Advisory Board from Pfizer; Board—Grant from Bayer; Grant from Janssen; Speaker—Grant from Takeda. BPV reports Advisory Board and Speaker from BMS MSD Oncology and Astellas Pharma; Advisory Board from AstraZeneca and Novartis; Speaker from Bayer, Roche, Ipsen and Eusa Pharma; Speaker and other from Merck and Pfizer. CSR reports Advisory Board and Personal Feels from Bristol-Myers Squibb (Inst), Pfizer, Sanofi, MSD, Ipsen, Roche and Astellas; Grant from Ipsen; from Bayer. JAA reports Advisory Board and Speaker from Pfizer and Merck; Adisory Board from Astellas, MSD, AstraZeneca, Bayer, Novartis, Ipsen and Eusa; Advisory Board and Grant from BMS. IPF reports Advisory Board from Ipsem, Pfizer and MSD; Speaker from Pfizer and Ipsen; Other from Ipsen and Pfizer. EGD reports Board—Speaker—Grant—Non-financial Support from Sanofi, Janssen, Astellas, Bayer, Roche, BMS, Ipsen and Pfizer; Advisory Board—Non-financial Support from AstraZeneca; Advisory Board—Speaker from Rovi, Daiichi Sankyo, Advanced Accelerator Applications and Lilly; Advisory Board—Speaker—Non-financial Support from Eisai; Advisory Board—Speaker—Grant from Merck. JLS reports Advisory Board and Speaker from Ipsen and MSD; Speaker from BMS, Eusa and Pfizer. AGdA has received research funding from Astellas, travel grants from Astellas, Jansen, Sanofi, BMS, Roche, Pfizer, MSD, AZ and Ipsen and honoraria for speaker engagements, advisory boards and continuous medical education from Janssen, Astellas, Sanofi, Bayer, Roche, Ipsen, BMS, MSD, Pfizer, Eusa Pharma, Eisai, Novartis, AAA and AstraZeneca. NLM have nothing to disclose.
: Not applicable.
: Not applicable.